Breakthrough SARS-CoV-2 Infection Outcomes in Vaccinated Patients with Chronic Liver Disease and Cirrhosis: A National COVID Cohort Collaborative Study

BACKGROUND AND AIMS: The incidence and outcomes of breakthrough SARS-CoV-2 infections in vaccinated chronic liver disease (CLD) patients have not been well-characterized in non-veteran populations. We used the National COVID Cohort Collaborative (N3C), a dataset of 10.7 million patients, of whom 0.9...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Jin, Digitale, Jean C., Pletcher, Mark J., Lai, Jennifer C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275663/
https://www.ncbi.nlm.nih.gov/pubmed/35821984
http://dx.doi.org/10.1101/2022.02.25.22271490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275663/
https://www.ncbi.nlm.nih.gov/pubmed/35821984
http://dx.doi.org/10.1101/2022.02.25.22271490

Ejemplares similares